New synergistic combinations of differentiation-inducing agents in the treatment of acute promyelocytic leukemia cells-Reference-Cited by-同舟云学术

New synergistic combinations of differentiation-inducing agents in the treatment of acute promyelocytic leukemia cells

Published:2018-05 Issue: Volume:68 Page:98-104
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Amanzadeh Amir,Molla-kazemiha Vahid,Samani Saeed,Habibi-Anbouhi Mahdi,Azadmanesh Kayhan,Abolhassani Mohsen,Shokrgozar Mohammad Ali

Funder

Pasteur Institute of Iran and Deputy of Research and Technology, Ministry of Health and Medical Education, Medical Sciences of Iran

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference50 articles.

1. Differentiation therapy of leukemia: achievements, limitations and future prospects;Hozumi;Int. J. Hematol.,1998

2. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds;Collins;Proc. Natl. Acad. Sci. U. S. A.,1978

3. Terminal differentiation of human acute promyelocytic leukemia (APL) cells induced by Tanshinone II A in primary culture;Liang;Hua xi yi ke da xue xue bao = J. West China Univ. Med. Sci. = Huaxi yike daxue xuebao,2000

4. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML;Kakizuka;Cell,1991

5. Advances in therapies for acute promyelocytic leukemia;Kamimura;Cancer Sci.,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thiobenzamide-based ruthenium complexes: chemical reactivity and promising biological investigations against Leukemia cancer cells;Transition Metal Chemistry;2024-07-06

2. CD44: a cancer stem cell marker and therapeutic target in leukemia treatment;Frontiers in Immunology;2024-04-26

3. DDX5-targeting fully human monoclonal autoantibody inhibits proliferation and promotes differentiation of acute promyelocytic leukemia cells by increasing ROS production;Cell Death & Disease;2020-07

4. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance;Cancer Research;2019-09-13